XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,231,784 | -75.9% | 34,417 | -73.4% | 0.03% | -78.5% |
| Q4 2022 | $5,102,912 | +37.3% | 129,417 | +25.7% | 0.12% | +39.1% |
| Q3 2022 | $3,717,000 | -29.0% | 102,977 | -40.2% | 0.09% | -37.0% |
| Q2 2022 | $5,234,000 | +496.8% | 172,071 | +500.0% | 0.14% | +527.3% |
| Q1 2022 | $877,000 | +33.7% | 28,679 | -42.6% | 0.02% | +4.8% |
| Q4 2019 | $656,000 | +45.5% | 50,000 | 0.0% | 0.02% | +16.7% |
| Q3 2019 | $451,000 | -8.5% | 50,000 | 0.0% | 0.02% | +50.0% |
| Q2 2019 | $493,000 | -3.0% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $508,000 | +60.8% | 50,000 | 0.0% | 0.02% | +23.1% |
| Q4 2018 | $316,000 | +59.6% | 50,000 | +233.3% | 0.01% | +225.0% |
| Q3 2018 | $198,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 467,368 | $7,188,000 | 3.91% |
| Ghost Tree Capital, LLC | 700,000 | $10,766,000 | 2.40% |
| BVF INC/IL | 3,499,346 | $53,820,000 | 2.12% |
| DAFNA Capital Management LLC | 346,535 | $5,330,000 | 1.59% |
| Parkman Healthcare Partners LLC | 361,689 | $5,563,000 | 1.42% |
| KNOTT DAVID M | 200,000 | $3,076,000 | 1.39% |
| Soleus Capital Management, L.P. | 558,117 | $8,584,000 | 1.13% |
| Avoro Capital Advisors LLC | 2,800,000 | $43,064,000 | 0.74% |
| NEA Management Company, LLC | 992,107 | $15,259,000 | 0.40% |
| Orbimed Advisors | 2,497,917 | $38,418,000 | 0.34% |